U
HQCL

UBS’s Hanwha Q CELLS Co., Ltd. HQCL Stock Holding History

UBS’s Portfolio HQCL Stock Details HQCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-40
Closed -$1K – 11045
2014
Q1 		$1K Buy
+40
New +$1.23K ﹤0.01% 10268
2013
Q4 		– Sell
-510
Closed -$23K – 10988
2013
Q3 		$23K Sell
510
-600
-54% -$19.8K ﹤0.01% 7900
2013
Q2 		$23K Buy
+1,110
New +$14.7K ﹤0.01% 7735

Other funds holding HQCL

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
SCM
Seamans Capital Management Boston, Massachusetts $30.2M AUM 15.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
FA
FDx Advisors Chicago, Illinois $313M AUM 18.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS's HQCL Position: Q3 2014 in Review

UBS increased its Hanwha Q CELLS Co., Ltd. (HQCL) stake by 34% in Q3 2014, buying an estimated $7.88K and bringing the position to 1,354 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #7407.

UBS first reported a position in HQCL in Q2 2013 and has held it in 6 quarters since. The position peaked at $79K in Q1 2014. 33 funds tracked by Wall St. Rank hold HQCL as of Q3 2014.

  • UBS held 1,354 shares of Hanwha Q CELLS Co., Ltd. worth $32K as of Q3 2014.
  • UBS bought 342 Hanwha Q CELLS Co., Ltd. shares in Q3 2014, an estimated $7.88K.
  • Hanwha Q CELLS Co., Ltd. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7407 holding.
  • UBS first reported a position in Hanwha Q CELLS Co., Ltd. in Q2 2013 and has held it in 6 quarters since.
  • UBS's Hanwha Q CELLS Co., Ltd. position peaked at $79K in Q1 2014.
  • 33 funds tracked by Wall St. Rank held Hanwha Q CELLS Co., Ltd. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.